What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of study are Internal medicine, Immunology, Surgery, Telomerase and Molecular biology.
His research is interdisciplinary, bridging the disciplines of Gastroenterology and Internal medicine.
His Immunology research includes themes of Case-control study and Oncology.
He interconnects Young adult, Malignancy and Histopathology in the investigation of issues within Surgery.
His Telomerase research includes elements of Telomere, Malignant transformation and Cellular differentiation.
His Molecular biology study combines topics from a wide range of disciplines, such as Chromatin immunoprecipitation and Transactivation.
His most cited work include:
- Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). (480 citations)
- Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population (320 citations)
- Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. (293 citations)
What are the main themes of his work throughout his whole career to date?
Magnus Björkholm focuses on Internal medicine, Immunology, Surgery, Oncology and Gastroenterology.
His study in Internal medicine concentrates on Multiple myeloma, Hematology, Chemotherapy, Lymphoma and Cancer.
His biological study spans a wide range of topics, including Cancer research and Telomerase reverse transcriptase.
His study in Immunology focuses on Lymphocyte, Antibody, Leukemia, Antigen and Chronic lymphocytic leukemia.
His Lymphocyte study combines topics in areas such as Concanavalin A, Pokeweed mitogen, Disease and DNA synthesis.
His work carried out in the field of Leukemia brings together such families of science as Myeloid and Myeloid leukemia.
He most often published in these fields:
- Internal medicine (48.68%)
- Immunology (29.06%)
- Surgery (16.23%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (48.68%)
- Oncology (15.66%)
- Cancer research (14.53%)
In recent papers he was focusing on the following fields of study:
Magnus Björkholm mainly investigates Internal medicine, Oncology, Cancer research, Cancer and Immunology.
His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine.
His study on Oncology also encompasses disciplines like
- Myeloid leukemia which connect with Leukemia,
- Chemoimmunotherapy together with Follicular lymphoma,
- Malignancy and related Cohort.
His Cancer research research is multidisciplinary, relying on both Carcinogenesis, DNA methylation and Telomerase, Telomerase reverse transcriptase.
His Telomerase study incorporates themes from Telomere and Molecular biology.
The study incorporates disciplines such as Odds ratio, Pathology, Population based study and Genetic predisposition in addition to Cancer.
Between 2012 and 2021, his most popular works were:
- Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population (320 citations)
- Acute myeloid leukaemia. (262 citations)
- Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells (172 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His primary scientific interests are in Internal medicine, Cancer, Oncology, Cancer research and Surgery.
His research related to Hematology, Relative survival, Case-control study, Multiple myeloma and Hazard ratio might be considered part of Internal medicine.
His study in Cancer is interdisciplinary in nature, drawing from both Myotonic dystrophy and Cause of death.
His Oncology research incorporates themes from Head and neck cancer, Malignancy, Immunology and Cohort.
His Immunology research is multidisciplinary, incorporating perspectives in Haematopoiesis and Chemotherapy.
His research integrates issues of TaqMan, Urine and Telomerase, Telomerase reverse transcriptase in his study of Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
